Document Detail


Bifunctional Tungstate Catalyst for Chemical Fixation of CO(2) at Atmospheric Pressure.
MedLine Citation:
PMID:  22674893     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
No pressure: A simple monomeric tungstate, [WO(4) ](2-) , serves as a highly efficient homogeneous catalyst for various transformations of CO(2) at atmospheric pressure. The tungsten-oxo moiety activates CO(2) and the substrate simultaneously. The catalyst system is high yielding and applicable to a wide range of substrates such as amines, 2-aminobenzonitriles, and propargylic alcohols.
Authors:
Toshihiro Kimura; Keigo Kamata; Noritaka Mizuno
Related Documents :
16858303 - Hemodynamic effects of dexmedetomidine in patients after cardiac surgery.
3359583 - Improvement in exercise capacity and exercise hemodynamics 3 months after double-balloo...
20056433 - Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrat...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-5
Journal Detail:
Title:  Angewandte Chemie (International ed. in English)     Volume:  -     ISSN:  1521-3773     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370543     Medline TA:  Angew Chem Int Ed Engl     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Affiliation:
Department of Applied Chemistry, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 (Japan) http://park.itc.u-tokyo.ac.jp/mizuno/
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Associations for change in physical and psychological factors and treatment response following exerc...
Next Document:  Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.